Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis
Titel:
Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis
Auteur:
Shank, B.R. Primeaux, B. Yeung, E.K. Horowitz, S.B. Lee, I.Y. Roccograndi, L. Feng, L. Kaufman, G.P. Lee, H.C. Manasanch, E.E. Patel, K.K. Orlowski, R.Z. Weber, D.M. Becnel, M.R. Thomas, S.K.